Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

9.285
-0.530-5.40%
Volume:92.21M
Turnover:878.44M
Market Cap:106.98B
PE:23.34
High:10.040
Open:9.880
Low:9.235
Close:9.815
52wk High:10.720
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:1.56
T/O Rate:0.80%
Dividend:0.34
Dividend Rate:3.64%
EPS(LYR):0.398
ROE:20.90%
ROA:10.70%
PB:2.43
PE(LYR):23.34
PS:2.92

Loading ...

CSPC Pharmaceutical - Sys6010 Granted Breakthrough Therapy Designation by Nmpa in China for Nsclc

THOMSON REUTERS
·
Sep 15

CSPC Pharmaceutical Group Stock Sheds 1.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 15

Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice

Stock News
·
Sep 15

CSPC Pharmaceutical Group Stock Rallies 1.8% in Hong Kong

Dow Jones
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty

Stock News
·
Sep 11

CSPC Pharmaceutical Group Stock Slips 3.6% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 10

Global Equities Roundup: Market Talk

Dow Jones
·
Sep 10

Hong Kong Market Flash | CSPC Pharma Drops Over 4% as Lp(a) HORIZON Study Setback May Pressure Participants Including the Company

Stock News
·
Sep 10

CSPC Pharma's Clinical Data Presentations Could be Near-Term Share Catalysts

Dow Jones
·
Sep 10

Movement Alert|CSPC PHARMA Falls 3.3% in Regular Trading, Pharma Sector Under Broad Selling Pressure Amid Global Risk-Off

Market Focus
·
Sep 10

CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug

MT Newswires Live
·
Sep 09

CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval in China

Reuters
·
Sep 09

CSPC PHARMA Wins NMPA Approval to Start Clinical Trial for First Long-Acting Subcutaneous Rotigotine Injection

Bulletin Express
·
Sep 09

CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China

Stock News
·
Sep 09

CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection

Stock News
·
Sep 09

CSPC Pharma Wins China Clinical Trial Clearance for Syh9102 Goserelin Injection

Reuters
·
Sep 09

CSPC Pharmaceutical - Goserelin Sustained-Release Injection (Syh9102 Injection) Obtains Clinical Trial Approval in China

THOMSON REUTERS
·
Sep 09

Movement Alert|CSPC PHARMA Falls 3.03% in Regular Trading, Global Market Selloff Drags Down Pharmaceutical Sector

Market Focus
·
Sep 09

CSPC Pharmaceutical Gets China Approval for Eye Drug Clinical Trials

MT Newswires Live
·
Sep 08